Herbert Chen, MD Print Friendly PageFaculty, University of Wisconsin School of Medicine and Public Health
Dr. Chen earned his undergraduate degree from Stanford University and his medical degree from Duke University. He completed his residency in general surgery at Johns Hopkins Hospital, followed by a surgical oncology/endocrinology fellowship at Johns Hopkins Hospital and oncology center.
Dr. Chen is certified by the American Board of Surgery. He specializes in endocrine surgery, thyroid disease, hyperparathyroidism, adrenal tumors and neuroendocrine tumors. Dr. Chen is an expert in thyroid surgery (thyroidectomy, neck dissection), parathyroidectomy (minimally invasive radioguided parathyroidectomy – MIRP), adrenalectomy (laparoscopic), minimally invasive endocrine surgery and treatment of carcinoids.
UW Health Clinics
UW School of Medicine and Public Health
Professional Certifications and Education
Postdoctoral Research Fellowship, The Johns Hopkins Oncology Center, Baltimore, MD, 1994-1997 Fellowship in Surgical Oncology, The Johns Hopkins Hospital, Baltimore, MD, 1998-2000
Johns Hopkins Hospital, Baltimore, MD
Johns Hopkins Hospital, Baltimore, MD
Duke University School of Medicine, Durham, NC
Best Doctors® in America 2008-2013
|Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.|
Our doctors provide a wide range of services. The following list represents some, but not all, of the procedures offered by this physician.
Dr. Chen conducts basic science research at the University of Wisconsin Carbone Cancer Center. His research program investigates the development, progression, and treatment of endocrine tumors including gastrointestinal carcinoids, thyroid cancer, and pancreatic islet cell tumors.
Jang S Yu XM Odorico S Clark M Jaskula-Sztul R Schienebeck CM Kupcho KR Harrison AD Winston-McPherson GN Tang W Chen H .
Novel analogs targeting histone deacetylase suppress aggressive thyroid cancer cell growth and induce re-differentiation. Cancer Gene Ther. 2015 Aug;22(8):410-6
[PubMed ID: 26251030]
Ritter K Elfenbein D Schneider DF Chen H Sippel RS .
Hypoparathyroidism after total thyroidectomy: incidence and resolution. J Surg Res. 2015 Aug;197(2):348-53
[PubMed ID: 25982044]
Lou I Schneider DF Leverson GE Sippel RS Chen H .
Do additional imaging studies change operative management in patients undergoing adrenalectomy? Surgery. 2015 Jul 29;
[PubMed ID: 26233809]
Chen H Yu H Wang J Zhang Z Gao Z Chen Z Lu Y Liu W Jiang D Zheng SL Wei GH Issacs WB Feng J Xu J .
Systematic enrichment analysis of potentially functional regions for 103 prostate cancer risk-associated loci. Prostate. 2015 Jul;75(12):1264-76
[PubMed ID: 26015065]
Pozo K Hillmann A Augustyn A Plattner F Hai T Singh T Ramezani S Sun X Pfragner R Minna JD Cote GJ Chen H Bibb JA Nwariaku FE .
Differential expression of cell cycle regulators in CDK5-dependent medullary thyroid carcinoma tumorigenesis. Oncotarget. 2015 May 20;6(14):12080-93
[PubMed ID: 25900242]
Somnay YR Weinlander E Alfhefdi A Schneider D Sippel RS Chen H .
Radioguided parathyroidectomy for tertiary hyperparathyroidism. J Surg Res. 2015 May 15;195(2):406-11
[PubMed ID: 25770735]
Oltmann SC Madkhali TM Sippel RS Chen H Schneider DF .
Kidney Disease Improving Global Outcomes guidelines and parathyroidectomy for renal hyperparathyroidism. J Surg Res. 2015 Apr 18;
[PubMed ID: 25982045]
Nankee L Chen H Schneider DF Sippel RS Elfenbein DM .
Substernal goiter: when is a sternotomy required? J Surg Res. 2015 Apr 18;
[PubMed ID: 25976851]
Ferguson LR Chen H Collins AR Connell M Damia G Dasgupta S Malhotra M Meeker AK Amedei A Amin A Ashraf SS Aquilano K Azmi AS Bhakta D Bilsland A Boosani CS Chen S Ciriolo MR Fujii H Guha G Halicka D Helferich WG Keith WN Mohammed SI Niccolai E Yang X Honoki K Parslow VR Prakash S Rezazadeh S Shackelford RE Sidransky D Tran PT Yang ES Maxwell CA .
Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition. Semin Cancer Biol. 2015 Apr 10;
[PubMed ID: 25869442]
Xu J Bergren R Schneider D Chen H Sippel RS .
Thyroglobulin antibody resolution after total thyroidectomy for cancer. J Surg Res. 2015 Apr 2;
[PubMed ID: 25930167]
Elfenbein DM Schneider DF Havlena J Chen H Sippel RS .
Clinical and socioeconomic factors influence treatment decisions in Graves' disease. Ann Surg Oncol. 2015 Apr;22(4):1196-9
[PubMed ID: 25245130]
Elfenbein DM Weber S Schneider DF Sippel RS Chen H .
CaPTHUS scoring model in primary hyperparathyroidism: can it eliminate the need for ioPTH testing? Ann Surg Oncol. 2015 Apr;22(4):1191-5
[PubMed ID: 25212837]
Tevis SE Chen H .
Surgery. Papillary thyroid cancer--how aggressive should surgery be? Nat Rev Endocrinol. 2015 Apr;11(4):195-6
[PubMed ID: 25687998]
Ayers RR Tobin K Sippel RS Balentine C Elfenbein D Chen H Schneider DF .
Does levothyroxine administration impact parathyroid localization? J Surg Res. 2015 Mar 31;
[PubMed ID: 25917998]
Sohn JA Oltmann SC Schneider DF Sippel RS Chen H Elfenbein DM .
Is intraoperative parathyroid hormone testing in patients with renal insufficiency undergoing parathyroidectomy for primary hyperparathyroidism accurate? Am J Surg. 2015 Mar;209(3):483-7
[PubMed ID: 25556028]
Rajaei MH Oltmann SC Schneider DF Sippel RS Chen H .
Outcomes after subtotal parathyroidectomy for primary hyperparathyroidism due to hyperplasia: significance of whole vs. partial gland remnant. Ann Surg Oncol. 2015 Mar;22(3):966-71
[PubMed ID: 25245126]
Oltmann SC Brekke AV Schneider DF Schaefer SC Chen H Sippel RS .
Preventing postoperative hypocalcemia in patients with Graves disease: a prospective study. Ann Surg Oncol. 2015 Mar;22(3):952-8
[PubMed ID: 25212835]
Liu S Jin K Hui Y Fu J Jie C Feng S Reisman D Wang Q Fan D Sukumar S Chen H .
HOXB7 promotes malignant progression by activating the TGFβ signaling pathway. Cancer Res. 2015 Feb 15;75(4):709-19
[PubMed ID: 25542862]
Oltmann SC Schneider DF Chen H Sippel RS .
All thyroid ultrasound evaluations are not equal: sonographers specialized in thyroid cancer correctly label clinical N0 disease in well differentiated thyroid cancer. Ann Surg Oncol. 2015 Feb;22(2):422-8
[PubMed ID: 25234019]
Rajaei MH Bentz AM Schneider DF Sippel RS Chen H Oltmann SC .
Justified follow-up: a final intraoperative parathyroid hormone (ioPTH) Over 40 pg/mL is associated with an increased risk of persistence and recurrence in primary hyperparathyroidism. Ann Surg Oncol. 2015 Feb;22(2):454-9
[PubMed ID: 25192677]